In 2011, Watanabe et al. demonstrated that either TSN alone or a combination of TSN and IFNα could inhibit hepatitis C virus (HCV) infection in a human hepatoma cell line (Huh7; Watanabe et al., 2011). This evidence concerns the gene TSN and hepatocellular carcinoma.